Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia

被引：41

作者：

Rickerts, V.

Atta, J.

Herrmann, S.

Jacobi, V.

Lambrecht, E.

Bialek, R.

Just-Nuebling, G.

机构：

[1] Klinikum JW Goethe Univ, Med Klin 2, Frankfurt, Germany

[2] Klinikum JW Goethe Univ, Inst Diagnost & Intervent Radiol, Frankfurt, Germany

[3] Klinikum JW Goethe Univ, Senckenberg Zentrum Pathol, Frankfurt, Germany

[4] Univ Tubingen, Inst Trop Med, Tubingen, Germany

来源：

MYCOSES | 2006年 / 49卷

关键词：

liposomal amphotericin B; posaconazole; mucormycosis; antifungal combination;

D O I：

10.1111/j.1439-0507.2006.01299.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The combination of resection of infected tissue and antifungal therapy is the treatment of choice in mucormycosis. In disseminated mucormycosis, where surgery is impossible, the mortality is almost 90%. We report the first case of disseminated mucormycosis that was cured with a combination therapy of liposomal amphotericin B and posaconazole without surgical intervention.

引用

收藏

页码：27 / 30

页数：4

相关论文

共 16 条

[1] Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection [J].

Barchiesi, F ;

Spreghini, E ;

Schimizzi, AM ;

Maracci, M ;

Giannini, D ;

Carle, F ;

Scalise, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3312-3316

[2] PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue [J].

Bialek, R ;

Konrad, F ;

Kern, J ;

Aepinus, C ;

Cecenas, L ;

Gonzalez, GM ;

Just-Nübling, G ;

Willinger, B ;

Presterl, E ;

Lass-Flörl, C ;

Rickerts, V .

JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (11) :1180-1184

[3] Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo [J].

Cacciapuoti, A ;

Gurnani, M ;

Halpern, J ;

Norris, C ;

Patel, R ;

Loebenberg, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :638-642

[4] Activity of posaconazole in treatment of experimental disseminated zygomycosis [J].

Dannaoui, E ;

Meis, JFGM ;

Loebenberg, D ;

Verweij, PE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3647-3650

[5] In vitro susceptibilities of zygomycetes to conventional and new antifungals [J].

Dannaoui, E ;

Meletiadis, J ;

Mouton, JW ;

Meis, JFGM ;

Verweij, PE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :45-52

[6] Improved outcome of zygomycosis in patients with hematological diseases? [J].

Gleissner, B ;

Schilling, A ;

Anagnostopolous, I ;

Siehl, I ;

Thiel, E .

LEUKEMIA & LYMPHOMA, 2004, 45 (07) :1351-1360

[7] Posaconazole as salvage therapy for zygomycosis [J].

Greenberg, RN ;

Mullane, K ;

van Burik, JAH ;

Raad, I ;

Abzug, MJ ;

Anstead, G ;

Herbrecht, R ;

Langston, A ;

Marr, KA ;

Schiller, G ;

Schuster, M ;

Wingard, JR ;

Gonzalez, CE ;

Revankar, SG ;

Corcoran, G ;

Kryscio, RJ ;

Hare, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :126-133

[8] Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae [J].

Ibrahim, AS ;

Avanessian, V ;

Spellberg, B ;

Edwards, JE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3343-3344

[9] Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases [J].

Kontoyiannis, DP ;

Lionakis, MS ;

Lewis, RE ;

Chamilos, G ;

Healy, M ;

Perego, C ;

Safdar, A ;

Kantarjian, H ;

Champlin, R ;

Walsh, TJ ;

Raad, II .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (08) :1350-1360

[10]

Lewis RE, 2004, ANTIMICROB AGENTS CH, V48, P3211, DOI 10.1128/AAC.48.8.3211-3212.2004